trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Immunotherapy treatments for cancer can be administered in cycles to allow the body time to rest and recover.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that immunotherapy treatments for cancer can be administered in cycles to allow the body time to rest and recover?

Yes. Immunotherapy and other cancer treatments are frequently administered in cycles with scheduled breaks to manage toxicity and allow patients time to recover, which is supported by clinical protocols and mathematical modeling.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The claim states that cancer immunotherapy treatments can be administered in cycles to allow rest and recovery. Retrieved papers discuss cyclic dosing schedules (e.g., Paper 2 on 28-day cycles and Paper 4 on cyclic CAR-T cell administration) which optimize outcomes and manage patient toxicity. Thus, the claim is supported by the literature.

Evidence for · 2
Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer
2021
Discusses traditional and modified dosing schedules in cycles (such as 28-day cycles) used in cancer treatment to manage toxicity and allow recovery.
Get citation
Winer, A., Handorf, E., & Dotan, E. (2021). Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer. doi.org. https://doi.org/10.1093/jncics/pkab074

See more details
More for · 1
CAR-T cell therapy for glioblastoma: insight from mathematical modeling.
2025
Demonstrates through mathematical modeling that cyclic administration of CAR-T cell immunotherapy outperforms single-dose strategies.
Get citation
M, S., Z, S., MJ, P., M, B., & U, F. (2025). CAR-T cell therapy for glioblastoma: insight from mathematical modeling.. doi.org. https://doi.org/10.3389/fimmu.2025.1563829

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work